{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-25-year-minimum-archiving-and-sponsor-responsibility”
},
“headline”: “SOP for 25-Year Minimum Archiving and Sponsor Responsibility”,
“description”: “This SOP outlines procedures for ensuring compliance with EMA and EU CTR requirements on minimum 25-year archiving of clinical trial records. It defines sponsor responsibilities, secure storage standards, premature destruction prevention, and inspection readiness obligations.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for 25-Year Minimum Archiving and Sponsor Responsibility

Purpose

The purpose of this SOP is to define requirements and processes for archiving essential clinical trial records for a minimum of 25 years, in compliance with the EU Clinical Trials Regulation (EU CTR 536/2014) and EMA guidance. This SOP ensures sponsor accountability for secure, long-term storage of both paper and electronic records.

Scope

This SOP applies to sponsors, CROs, investigators, and QA personnel involved in archiving of trial master files (TMFs), investigator site files (ISFs), safety records, and essential clinical trial documents. It covers responsibilities, archiving standards, premature destruction prevention, and regulatory inspection readiness.

Responsibilities

• Sponsor: Ensures compliance with 25-year archiving, oversees CROs and sites, and funds secure long-term storage.
• Investigator: Maintains investigator site records and ensures transfer to secure archives.
• CRO: Supports sponsor in TMF/ISF maintenance and vendor oversight.
• QA: Audits archive facilities and processes to ensure compliance.
• Archive Vendor: Provides validated storage with environmental and security controls.

Accountability

The Sponsor is ultimately accountable for 25-year record retention compliance, regardless of delegation to CROs or archive vendors.

Procedure

1. Identification of Essential Records
1.1 Identify documents required for 25-year retention under EU CTR.
1.2 Include TMF, ISF, safety reports, informed consent forms, and regulatory correspondence.
1.3 Record in Essential Documents List (Annexure-1).

2. Secure Archiving
2.1 Store documents in validated archive facilities with environmental monitoring (temperature, humidity).
2.2 Maintain access logs.
2.3 Record in Archive Facility Log (Annexure-2).

3. Electronic Records
3.1 Validate electronic archiving systems with audit trails.
3.2 Perform periodic data integrity checks.
3.3 Record in Electronic Archive Log (Annexure-3).

4. Prevention of Premature Destruction
4.1 Records must not be destroyed before 25 years unless authorized by EMA.
4.2 Maintain Destruction Prevention Log (Annexure-4).

5. Access and Confidentiality
5.1 Limit access to authorized staff only.
5.2 Document in Archive Access Log (Annexure-5).

6. Inspection Readiness
6.1 Maintain archives in inspection-ready condition.
6.2 Conduct periodic mock audits recorded in Archive Audit Log (Annexure-6).

Abbreviations

• SOP: Standard Operating Procedure
• TMF: Trial Master File
• ISF: Investigator Site File
• EMA: European Medicines Agency
• EU CTR: European Union Clinical Trials Regulation
• CRO: Contract Research Organization
• QA: Quality Assurance

Documents

1. Essential Documents List (Annexure-1)
2. Archive Facility Log (Annexure-2)
3. Electronic Archive Log (Annexure-3)
4. Destruction Prevention Log (Annexure-4)
5. Archive Access Log (Annexure-5)
6. Archive Audit Log (Annexure-6)

References

• EU Clinical Trials Regulation (EU CTR 536/2014)
• European Medicines Agency (EMA)
• ICH GCP E6(R2)

Version: 1.0

Approval Section

Annexures

Annexure-1: Essential Documents List

Annexure-2: Archive Facility Log

Annexure-3: Electronic Archive Log

Annexure-4: Destruction Prevention Log

Annexure-5: Archive Access Log

Annexure-6: Archive Audit Log

Revision History

For more SOPs visit: Pharma SOP

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-Data-Migration-and-Archiving-of-eClinical-Systems”
},
“headline”: “SOP for Data Migration and Archiving of eClinical Systems”,
“description”: “This SOP outlines standardized procedures for the migration and archiving of data in eClinical systems, ensuring integrity, traceability, and compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Data Migration and Archiving of eClinical Systems

Purpose

The purpose of this SOP is to define systematic procedures for data migration and archiving of eClinical systems used in clinical trials. It ensures that data is transferred, stored, and retained securely without loss of integrity, guaranteeing compliance with global regulatory standards including ICH GCP, FDA 21 CFR Part 11, EMA, CDSCO, and WHO requirements. This SOP also aims to establish long-term accessibility, auditability, and regulatory inspection readiness.

Scope

This SOP applies to all eClinical systems and databases, including Clinical Data Management Systems (CDMS), Electronic Data Capture (EDC), pharmacovigilance databases, safety reporting systems, laboratory systems, eTMF, and ISF-related archives. It covers migration between systems, archiving of completed trial data, validation of transfers, and secure long-term retention.

Responsibilities

• System Owner: Ensures proper planning and execution of data migration and archiving activities.
• Data Manager: Verifies completeness, accuracy, and consistency of migrated/archived data.
• IT Administrator: Implements migration tools, ensures data encryption, and maintains system access logs.
• Principal Investigator (PI): Confirms site-level records are properly archived.
• Sponsor/CRO: Provides oversight and ensures global compliance with data retention policies.
• QA Officer: Audits migration and archiving processes for compliance with SOP and regulatory standards.

Accountability

The sponsor and system owner are accountable for ensuring that data migration and archiving follow validated, documented, and regulatory-compliant processes. Data managers are accountable for validation, reconciliation, and traceability of archived data.

Procedure

1. Planning for Migration and Archiving
Develop a Data Migration and Archiving Plan (DMAP) before initiating migration.
Define scope (systems, datasets, timeframe) and assign responsibilities.
Conduct risk assessment and identify potential risks such as data loss, corruption, or incompatibility.

2. Pre-Migration Activities
Perform a full backup of source data before migration.
Lock down source system for data entry to prevent changes during migration.
Verify availability of required hardware, software, and secure storage media.

3. Data Migration Process
Use validated tools for migration, ensuring all metadata, audit trails, and timestamps are preserved.
Transfer data in encrypted format to target system or archive repository.
Document migration details in Data Migration Log (Annexure-1).

4. Post-Migration Verification
Validate migrated data by comparing record counts, field-level accuracy, and consistency against source.
Resolve discrepancies immediately and document corrective actions.
File verification reports in TMF (Annexure-2).

5. Archiving of Completed Trial Data
Archive trial data once database is locked and trial reports are finalized.
Store in secure repositories with redundancy (onsite, offsite, and cloud, if validated).
Maintain long-term access controls and user logs.

6. Access and Retrieval
Access to archived data must be authorized by PI or sponsor only.
Retrieval requests must be logged and justified in Access Log (Annexure-3).

7. Retention Timelines
Retain archived trial data for a minimum of 15 years or per regional regulations (e.g., EU 25 years, US 15 years).
Document retention policies in DMAP.

8. Disaster Recovery for Archives
Maintain duplicate archives in secure offsite storage.
Test retrieval from archives at least once annually.
Document results in Archive Verification Log (Annexure-4).

9. Documentation and Auditing
Maintain complete logs of migration, validation, and archiving activities.
QA must perform annual audits of archived data integrity and retrievability.

10. Archiving of Paper Records
Paper ISF and TMF documents must be archived in fireproof, humidity-controlled storage.
Indexes must be maintained for quick retrieval.

Abbreviations

• SOP: Standard Operating Procedure
• PI: Principal Investigator
• CRO: Clinical Research Organization
• QA: Quality Assurance
• TMF: Trial Master File
• ISF: Investigator Site File
• CDMS: Clinical Data Management System
• EDC: Electronic Data Capture
• LIMS: Laboratory Information Management System
• DMAP: Data Migration and Archiving Plan

Documents

1. Data Migration Log (Annexure-1)
2. Data Verification Report (Annexure-2)
3. Archive Access Log (Annexure-3)
4. Archive Verification Log (Annexure-4)

References

• ICH E6(R2) – Good Clinical Practice
• US FDA – 21 CFR Part 11
• EMA – Data Archiving and System Migration Guidelines
• CDSCO – Clinical Data Archiving Requirements
• WHO – Data Retention and Archiving Standards

Version: 1.0

Approval Section

Annexures

Annexure-1: Data Migration Log

Annexure-2: Data Verification Report

Annexure-3: Archive Access Log

Annexure-4: Archive Verification Log

Revision History

For more SOPs visit: Pharma SOP